Filters

Human TIE-1 Control/blocking peptide #2

Human TIE-1 Control/blocking peptide #2 size: 100 μg 188

Supplier ADI
Price 188
Size 100 μg
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
ELISA kit stock availabilityAvailable In Stock
ELISA's descriptionHuman TIE-1 Control/blocking peptide #2
CategoryAntibody Blocking Peptide
S typeSynthetic peptide (inquire immunogen)
Antibody's host issee techfile
PurificationAffinity purified
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), blocking peptide, humans , ssp
Description , The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists
Gene targetTIE-1 / #2
Short nameTIE-1 Control/blocking peptide #2
Technique For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear, This is called a negative control by blocking the WB antibody, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1, controls, peptides, blocking peptide
Species Humans, Human
Alternative name sapiens TIE-1 reference/inhibiting short protein sequence #2, H
Alternative techniquecontrols

Similar products

Subscribe to our Newsletter